Cargando…

MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPKα

Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide and can develop to nonalcoholic steatohepatitis and later hepatic cirrhosis with a high prevalence to hepatocellular carcinoma. Oxidative stress and chronic hepatic inflammation are implicated in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yuanjie, He, Chunping, Tan, Shiyun, Huang, Mengjun, Guo, Yitian, Li, Ming, Zhang, Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731301/ https://www.ncbi.nlm.nih.gov/pubmed/35004133 http://dx.doi.org/10.1155/2021/4853355

Ejemplares similares

MicroRNA-665-3p exacerbates nonalcoholic fatty liver disease in mice
por: Yu, Yuanjie, et al.
Publicado: (2022)

MicroRNA regulation of AMPK in nonalcoholic fatty liver disease
por: Sun, Hao, et al.
Publicado: (2023)

MicroRNAs in Nonalcoholic Fatty Liver Disease
por: Baffy, György
Publicado: (2015)

MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Fang, Zhiqiang, et al.
Publicado: (2021)

Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease
por: Soronen, Jarkko, et al.
Publicado: (2016)

Therapeutic Effects of microRNAs on Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review and Meta-Analysis
por: Zhu, Yuezhi, et al.
Publicado: (2023)

The interplay of microRNAs and transcription factors in autophagy regulation in nonalcoholic fatty liver disease
por: Kim, Yumi, et al.
Publicado: (2021)

A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo
por: Yan, Chenghui, et al.
Publicado: (2021)

A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease
por: Tan, Youwen, et al.
Publicado: (2014)

Thrap3 promotes nonalcoholic fatty liver disease by suppressing AMPK-mediated autophagy
por: Jang, Hyun-Jun, et al.
Publicado: (2023)

Association between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease: A Single-Center Clinical Study
por: Cai, Ou, et al.
Publicado: (2018)

Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis through Regulation of the PPARδ-AMPK-PGC-1α Pathway in Dyslipidemic Conditions
por: Han, Yoon-Mi, et al.
Publicado: (2020)

Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206
por: Chen, Xi, et al.
Publicado: (2021)

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
por: Chen, Xue-Yang, et al.
Publicado: (2019)

SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway
por: Kim, Da Eun, et al.
Publicado: (2020)

MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis
por: de Conti, Aline, et al.
Publicado: (2017)

Asprosin contributes to nonalcoholic fatty liver disease through regulating lipid accumulation and inflammatory response via AMPK signaling
por: Zhang, Bo, et al.
Publicado: (2023)

Citrus maxima and tea regulate AMPK signaling pathway to retard the progress of nonalcoholic fatty liver disease
por: Wen, Shuai, et al.
Publicado: (2022)

Increased RTN3 phenocopies nonalcoholic fatty liver disease by inhibiting the AMPK–IDH2 pathway
por: Huang, Hao, et al.
Publicado: (2023)

Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population
por: Pillai, Sneha S., et al.
Publicado: (2020)

Polymorphisms in MIR137HG and microRNA-137-regulated genes influence gray matter structure in schizophrenia
por: Wright, C, et al.
Publicado: (2016)

Homo Sapiens Circular RNA 0079993 (hsa_circ_0079993) of the POLR2J4 Gene Acts as an Oncogene in Colorectal Cancer Through the microRNA-203a-3p.1 and CREB1 Axis
por: Lu, Xiaohong, et al.
Publicado: (2019)

Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway
por: Yu, Peng, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2
por: Cui, Shichang, et al.
Publicado: (2018)

MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2
por: Cui, Shichang, et al.
Publicado: (2017)

MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2
por: Cui, Shichang, et al.
Publicado: (2022)

MicroRNAs in Nonalcoholic Fatty Liver Disease: Novel Biomarkers and Prognostic Tools during the Transition from Steatosis to Hepatocarcinoma
por: Gori, Manuele, et al.
Publicado: (2014)

Data on differentially expressed microRNAs in the liver between nonalcoholic fatty liver disease and normal Wistar rat using Solexa sequencing
por: Zhang, Deqing, et al.
Publicado: (2016)

Downregulation of miR-137 Facilitates CD4+ T Cell Pyroptosis in Systemic Lupus Erythematosus via Stimulating AMPK Pathway
por: Gong, Aimin, et al.
Publicado: (2023)

Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXRα signaling pathway
por: Lin, Min-Jie, et al.
Publicado: (2017)

Modulation of endoplasmic reticulum stress via sulforaphane-mediated AMPK upregulation against nonalcoholic fatty liver disease in rats
por: Mansour, Somaya Z., et al.
Publicado: (2022)

Lipotoxic hepatocytes promote nonalcoholic fatty liver disease progression by delivering microRNA-9-5p and activating macrophages
por: Liu, Hanyun, et al.
Publicado: (2021)

Loss of MicroRNA-137 Impairs the Homeostasis of Potassium in Neurons via KCC2
por: Mi, Ting-Wei, et al.
Publicado: (2020)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Erratum. A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo. Diabetes 2021;70:577–588
por: Yan, Chenghui, et al.
Publicado: (2021)

The AMPK pathway in fatty liver disease
por: Fang, Chunqiu, et al.
Publicado: (2022)

Global incidence and prevalence of nonalcoholic fatty liver disease
por: Teng, Margaret LP, et al.
Publicado: (2023)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5e2kc1sna9oj22kgijtufora37